发布求助
文献互助 智能选刊 最新文献

Praxis最新文献

筛选
英文 中文
[Uncommon Yet Severe: Metabolic Acidosis from Concurrent Use of Paracetamol and Flucloxacillin].
Praxis Pub Date : 2024-12-01 DOI: 10.23785/PRAXIS.2024.11.008
Nikolay Todorov, Patrick Bader
{"title":"[Uncommon Yet Severe: Metabolic Acidosis from Concurrent Use of Paracetamol and Flucloxacillin].","authors":"Nikolay Todorov, Patrick Bader","doi":"10.23785/PRAXIS.2024.11.008","DOIUrl":"https://doi.org/10.23785/PRAXIS.2024.11.008","url":null,"abstract":"<p><strong>Introduction: </strong>A 60-year-old polymorbid patient developed severe metabolic acidosis during weeks of treatment with flucloxacillin and paracetamol. The acidosis was triggered by an accumulation of 5-oxoproline due to pre-existing risk factors for glutathione deficiency as well as a ketoacidosis due to starvation. After treatment with N-acetylcysteine and hemofiltration, the acidosis completely resolved.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"113 11-12","pages":"325-328"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142855040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vaccination in adult patients with chronic lung diseases.
Praxis Pub Date : 2024-12-01 DOI: 10.23785/PRAXIS.2024.11.003
Maria Boesing, Werner Albrich, Pierre-Olivier Bridevaux, Florian Charbonnier, Christian Clarenbach, Jean-Marc Fellrath, Pietro Gianella, Lukas Kern, Tsogyal Latshang, Nikolay Pavlov, Michael Osthoff, Claudia Steurer-Stey, Christophe von Garnier, Jörg D Leuppi
{"title":"Vaccination in adult patients with chronic lung diseases.","authors":"Maria Boesing, Werner Albrich, Pierre-Olivier Bridevaux, Florian Charbonnier, Christian Clarenbach, Jean-Marc Fellrath, Pietro Gianella, Lukas Kern, Tsogyal Latshang, Nikolay Pavlov, Michael Osthoff, Claudia Steurer-Stey, Christophe von Garnier, Jörg D Leuppi","doi":"10.23785/PRAXIS.2024.11.003","DOIUrl":"https://doi.org/10.23785/PRAXIS.2024.11.003","url":null,"abstract":"<p><strong>Introduction: </strong>In Switzerland, additional vaccinations against influenza, COVID-19, Streptococcus pneumoniae and varicella zoster virus (VZV), are recommended for patients with chronic lung diseases such as COPD, asthma or interstitial lung disease, since infectious diseases often lead to exacerbation of lung diseases resulting in increased disease burden and mortality. In this review we give an overview on recommended vaccinations for patients with chronic lung diseases, also including vaccinations against pertussis and RSV, which are recommended in international guidelines. While continuous development of vaccines against S. pneumoniae has given rise to high-valency vaccines covering up to 68% of S. pneumoniae variants in individuals aged ≥65 years, vaccination rates in this age group remain low in Switzerland (10% in 2020). Vaccination rates are higher for influenza, and particularly high-dose vaccines account for high vaccination efficacy in years of low strain matching in individuals at risk. Although mortality of COVID-19 decreased since the emergence of the first SARS-CoV-2 variant, patients with chronic lung disease are still at increased risk for exacerbation, unless vaccinated with variant-adjusted vaccines. VZV and Bordetella pertussis vaccination has also significantly countered reactivation and infection rates, respectively, and subunit vaccines against VZV show long duration. However, pertussis vaccination is still limited by its fast waning. A glimpse into the future presumes the introduction of new higher-valence vaccinations against S. pneumoniae, and several types of RSV vaccines are expected to enter the Swiss market soon.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"113 11-12","pages":"297-305"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142855049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Rabies and mobility: 2025 update].
Praxis Pub Date : 2024-12-01 DOI: 10.23785/PRAXIS.2024.11.004
Alexia Anagnostopoulos, Anita Niederer-Loher, Daniela Hüssy, Cornelia Staehelin, Jan Fehr
{"title":"[Rabies and mobility: 2025 update].","authors":"Alexia Anagnostopoulos, Anita Niederer-Loher, Daniela Hüssy, Cornelia Staehelin, Jan Fehr","doi":"10.23785/PRAXIS.2024.11.004","DOIUrl":"https://doi.org/10.23785/PRAXIS.2024.11.004","url":null,"abstract":"<p><strong>Introduction: </strong>Switzerland has been considered free of terrestrial rabies for more than 20 years. Nevertheless, the topics of rabies and rabies vaccination are more relevant than ever. On the one hand, this is because the demand for vaccines is increasing due to the increasing mobility of humans and animals, and on the other hand, there are frequent vaccine supply shortages. Our article highlights the key points in the face of growing challenges.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"113 11-12","pages":"306-312"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142855031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Ultrasound-guided synovial biopsy].
Praxis Pub Date : 2024-12-01 DOI: 10.23785/PRAXIS.2024.11.006
Mauro Bachmann, Katharina Zachariassen, Chantal Pauli, Nina Colla, Oliver Distler, Raphael Micheroli
{"title":"[Ultrasound-guided synovial biopsy].","authors":"Mauro Bachmann, Katharina Zachariassen, Chantal Pauli, Nina Colla, Oliver Distler, Raphael Micheroli","doi":"10.23785/PRAXIS.2024.11.006","DOIUrl":"https://doi.org/10.23785/PRAXIS.2024.11.006","url":null,"abstract":"<p><strong>Introduction: </strong>A 47-year-old female presented with arthritis in the left hand's PIP III. Her symptoms were negative for connective tissue disease or spondyloarthritis, but she had HIV and hepatitis B. Initial tests showed no systemic inflammation or abnormal antibodies, and radiology revealed no bony changes. Despite a successful initial treatment with a Kenacort injection, arthritis recurred in both hands. A synovial biopsy via ultrasound revealed gout tophi, confirmed by dual-energy CT showing urate crystals in the soft tissue. Synovial biopsy is an effective, minimally invasive diagnostic tool for undifferentiated arthritis when other tests are inconclusive. Though puncture analysis remains the gold standard, it was not possible in this case due to lack of joint effusion.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"113 11-12","pages":"318-320"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142855036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[XDR tuberculosis, a challenge not just from a medical point of view].
Praxis Pub Date : 2024-12-01 DOI: 10.23785/PRAXIS.2024.11.007
Alexandra Schaeren, Johannes Nemeth, Bertram Feil, Benjamin Preiswerk
{"title":"[XDR tuberculosis, a challenge not just from a medical point of view].","authors":"Alexandra Schaeren, Johannes Nemeth, Bertram Feil, Benjamin Preiswerk","doi":"10.23785/PRAXIS.2024.11.007","DOIUrl":"https://doi.org/10.23785/PRAXIS.2024.11.007","url":null,"abstract":"<p><strong>Introduction: </strong>A young patient from Georgia presented with pulmonary XDR-tuberculosis after months of failed treatment in his home country. Based on genotypic examinations of the sputum samples and a Georgian antibiogram the diagnosis was confirmed and an empirical treatment was started. Despite many initial uncertainties and severe side effects over the course of the treatment, for which treatment adjustments were necessary, the therapy was succesfull with clear clinical and radiological response.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"113 11-12","pages":"321-324"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142855043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diät wirksamer auf Körpergewicht und HbA1c als Metformin und SGLT-2-Hemmer.
Praxis Pub Date : 2024-12-01 DOI: 10.23785/PRAXIS.2024.11.001
Thomas Rosemann
{"title":"Diät wirksamer auf Körpergewicht und HbA1c als Metformin und SGLT-2-Hemmer.","authors":"Thomas Rosemann","doi":"10.23785/PRAXIS.2024.11.001","DOIUrl":"https://doi.org/10.23785/PRAXIS.2024.11.001","url":null,"abstract":"<p><strong>Introduction: </strong></p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"113 11-12","pages":"292"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142855047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Alzheimer's disease - system prepardeness in the context of new developments].
Praxis Pub Date : 2024-12-01 DOI: 10.23785/PRAXIS.2024.11.002
Rafael Meyer, Andreas Monsch, Gilles Allali, Nadège Barro-Belaygues, Stefanie Becker, Markus Bürge, Giovanni B Frisoni, Dan Georgescu, Anton Gietl, Hans H Jung, Aurelien Lathuiliere, Kathrin Lindheimer, Karl-Olof Lovblad, Tatjana Meyer-Heim, Julius Popp, Olivier Rouaud, Marc Sollberger, Ansgar Felbecker
{"title":"[Alzheimer's disease - system prepardeness in the context of new developments].","authors":"Rafael Meyer, Andreas Monsch, Gilles Allali, Nadège Barro-Belaygues, Stefanie Becker, Markus Bürge, Giovanni B Frisoni, Dan Georgescu, Anton Gietl, Hans H Jung, Aurelien Lathuiliere, Kathrin Lindheimer, Karl-Olof Lovblad, Tatjana Meyer-Heim, Julius Popp, Olivier Rouaud, Marc Sollberger, Ansgar Felbecker","doi":"10.23785/PRAXIS.2024.11.002","DOIUrl":"https://doi.org/10.23785/PRAXIS.2024.11.002","url":null,"abstract":"<p><strong>Introduction: </strong>The possible authorisation of new monoclonal antibody therapies for Alzheimer's disease poses challenges for healthcare systems worldwide. In this paper, the Swiss Memory Clinics association (SMC) analyses the available resources and identifies potential health care shortages. Overcoming potential bottlenecks is a challenge that requires action at various levels. However, our analysis also shows that we are well positioned in Switzerland to integrate new developments into existing care structures.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"113 11-12","pages":"293-296"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142854906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clinical management of patients with cavernous malformations of the central nervous system: an update and recommendations for clinical practice].
Praxis Pub Date : 2024-12-01 DOI: 10.23785/PRAXIS.2024.11.005
Gioia Buschta, Luca Regli, Julia Velz
{"title":"[Clinical management of patients with cavernous malformations of the central nervous system: an update and recommendations for clinical practice].","authors":"Gioia Buschta, Luca Regli, Julia Velz","doi":"10.23785/PRAXIS.2024.11.005","DOIUrl":"https://doi.org/10.23785/PRAXIS.2024.11.005","url":null,"abstract":"<p><strong>Introduction: </strong>Cerebral cavernous malformations are benign vascular anomalies of the central nervous system (CNS). The clinical presentation of a cavernoma depends on its location. The majority of patients with cavernomas are asymptomatic. The most common symptoms include epileptic seizures, focal neurological deficits and/or headaches. The clinical management of cavernomas is challenging because numerous factors influence decision-making. These factors include the risk stratification of cavernoma-related hemorrhage, weighing the risks of surgical intervention against the natural course of the cavernoma and the clinical presentation. This article presents current guidelines and recommendations for clinical practice, based on the latest research findings and expert opinions. The article focuses on diagnostic approaches, risk stratification, therapeutic management and follow-up strategies.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"113 11-12","pages":"313-317"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142854980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sport-Paradox – Intensiver Sport erhöht das Risiko, eine ­relevante Koronar­stenose zu entwickeln.
Praxis Pub Date : 2024-11-01 DOI: 10.23785/PRAXIS.2024.10.001
Thomas Rosemann, Andrea Rosemann
{"title":"Sport-Paradox – Intensiver Sport erhöht das Risiko, eine ­relevante Koronar­stenose zu entwickeln.","authors":"Thomas Rosemann, Andrea Rosemann","doi":"10.23785/PRAXIS.2024.10.001","DOIUrl":"https://doi.org/10.23785/PRAXIS.2024.10.001","url":null,"abstract":"<p><strong>Introduction: </strong></p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"113 10","pages":"250-251"},"PeriodicalIF":0.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142813948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Anti-Hu syndrome - an unusual cause of vertigo].
Praxis Pub Date : 2024-11-01 DOI: 10.23785/PRAXIS.2024.10.008
Iris Neto, Cristian Camartin
{"title":"[Anti-Hu syndrome - an unusual cause of vertigo].","authors":"Iris Neto, Cristian Camartin","doi":"10.23785/PRAXIS.2024.10.008","DOIUrl":"https://doi.org/10.23785/PRAXIS.2024.10.008","url":null,"abstract":"<p><strong>Introduction: </strong>On the palliative care ward, we treated a man with a small cell lung cancer who was suffering from vertigo for six years, however the vertigo got stronger the last six months with pronounced coordination disorders. After several examinations, the cause was a paraneoplastic neurologic syndrome (PNS) with Hu-antibodies. PNS are various neurological malfunctions, which occur mostly in certain patterns. The pathogenesis is immune-mediated through a tumor. This is the reason why the treatment of the PNS is within the treatment of the tumor.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"113 10","pages":"280-282"},"PeriodicalIF":0.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142813979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信